Assessment of the Therapeutic Effect of Igs2.7, a Ck1Δ Protein Kinase Inhibitor, in Combination with Riluzole for the Treatment of Als-Associated Tdp-43 Proteinopathy

AuthID
P-01A-SWJ
14
Author(s)
Gomez-Almeria, M
·
Martinez-Gonzalez, L
·
Matos, AT
·
Rodriguez-Cueto, C
·
Martín-Baquero, R
·
de la Lastra, CP
·
Infantes, R
·
Fernández-Ruiz, J
·
Palomo, V
·
Gil, C
·
Martinez, A
·
de Lago, E
Tipo de Documento
Article
Year published
2026
Publicado
in NEUROPHARMACOLOGY, ISSN: 0028-3908
Volume: 285, Páginas: 110804 (14)
Indexing
Publication Identifiers
Pubmed: 41389988
SCOPUS: 2-s2.0-105024573121
Wos: WOS:001642567300001
Source Identifiers
ISSN: 0028-3908
Export Publication Metadata
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.